Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05813912
PHASE3

A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes

Sponsor: Novo Nordisk A/S

View on ClinicalTrials.gov

Summary

This study looks at how a new medicine insulin icodec helps in reducing blood sugar levels when given along with semaglutide in patients with type 2 diabetes. Participants will get the medicine insulin icodec once a week in the first part of the study (run-in period-26 weeks). Participants will only enter the second part of the study if the blood sugar levels have not reduced to normal. If blood sugar levels are normal after the first 26 weeks, participants will continue in a 5-week follow up period. In the second part of the study (intensification period-26 weeks), participants will get both insulin icodec and semaglutide once weekly after which they will continue in a 5-week follow up period. Participants will have to inject the study medicines once a week on the same day of the week in a skin fold in the thigh, upper arm or stomach. The study will last for about 13 months. Participants will get a blood glucose meter to check blood sugar levels. In addition, participants will be asked to enter blood sugar levels in the study phone. In addition, Participants will be asked to enter selected few blood sugar values (three times during the study) in a paper diary that will be provided to participants. Women cannot take part if pregnant, breast-feeding or plan to get pregnant during the study period.

Official title: Protocol Title: A Single Arm Study Investigating the Glycaemic Control and Safety of Adding Semaglutide to Insulin Icodec in Participants With Type 2 Diabetes Qualifying for Treatment Intensification Short Title: A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

148

Start Date

2023-09-22

Completion Date

2025-05-16

Last Updated

2026-06-03

Healthy Volunteers

No

Interventions

DRUG

Insulin Icodec

Participants will receive subcutaneously insulin icodec once weekly for 52 weeks.

DRUG

Semaglutide

Participants will receive once weekly semaglutide subcutaneously starting from 0.25 mg and dose increased up to 1 mg for 26 weeks.

Locations (39)

Edumed Broumov

Broumov, Czechia

DIAMIN

Chrudim, Czechia

Diabetologické centrum s.r.o.

Olomouc, Czechia

DIALINE s.r.o.

Plzeň 3, Czechia

Diabet2 s.r.o.

Prague, Czechia

Medicon a.s.

Prague, Czechia

Diabetologická a endokrinologická ambulance Praha

Prague, Czechia

EUC Klinika Praha a.s.

Prague, Czechia

Comfort Care Praha s.r.o.

Praha 4 - Chodov, Czechia

DiaPodi care s.r.o.

Soběslav I, Czechia

Hospital Canselor Tuanku Muhriz UKM

Cheras, Kuala Lumpur, Malaysia

Hospital Seri Manjung

Seri Manjung, Perak, Malaysia

Hospital Putrajaya

Putrajaya, Putrajaya, Malaysia

Hospital Miri

Miri, Sarawak, Malaysia

Universiti Teknologi MARA, Sungai Buloh Campus

Sungai Buloh, Selangor, Malaysia

Med. Cent. Diabet. Endo. Metabol. DIAB-ENDO-MET

Krakow, Lesser Poland Voivodeship, Poland

Metabolica Sp. z o.o.

Tarnów, Lesser Poland Voivodeship, Poland

Osrodek Badan Klinicznych "METABOLICA" lek. Robert Witek

Tarnów, Lesser Poland Voivodeship, Poland

Specjalistyczny Gabinet Diabetologiczny Radoslaw Rumianowski

Gorzów Wielkopolski, Lubusz Voivodeship, Poland

NBR Polska

Warsaw, Masovian Voivodeship, Poland

Osteo-Medic s.c. A. Racewicz, J. Supronik

Bialystok, Poland

Centrum Badan Klinicznych PI-House Sp. z o.o.

Gdansk, Poland

NZOZ Gdanska Poradnia Cukrzycowa Sp.z o.o.

Gdansk, Poland

NZOZ Gdanska Poradnia Cukrzycowa

Gdansk, Poland

Specjalistyczny Gabinet Diabetologiczny Radoslaw Rumianowski

Gorzów Wielkopolski, Poland

Centrum Medyczne Pratia Katowice

Katowice, Poland

Santa Sp. z o.o, Santa Familia Centrum Badan, Profilaktyki i Leczenia

Lodz, Poland

NBR Polska Tomasz Klodawski

Warsaw, Poland

Poradnia Chorob Metabolicznych w Wierzchoslawicach

Wierzchosławice, Poland

Wojewodzka Poradnia dla Chorych na Cukrzyce w Zabrzu

Zabrze, Poland

Santa Sp. z o.o, Santa Familia Centrum Badan, Profilaktyki i Leczenia

Lodz, Łódź Voivodeship, Poland

Clin. Centre Vojvodina, Clin. endocr., diab. and met. dis.

Novi Sad, Vojvodina, Serbia

CHC Zvezdara, Clinical department for endocrinology

Belgrade, Serbia

Clinical Hospital Centre Zemun

Belgrade, Serbia

Clinical Centre Kragujevac, Internal Diseases Clinic, Endocrinology department

Kragujevac, Serbia

King Chulalongkorn Memorial Hospital

Bangkok, Thailand

Rajavithi Hospital_Diabetes and Endocrinology

Bangkok, Thailand

Rajavithi Hospital

Bangkok, Thailand

Ramathibodi Hospital - Ped-Endo and Metabolism

Bangkok, Thailand